Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastases, Brain”

1,846 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,846 results

Testing effectiveness (Phase 2)Looking for participantsNCT06176261
What this trial is testing

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

Who this might be right for
Breast CancerBreast Cancer FemaleMetastatic Triple-Negative Breast Carcinoma+4 more
Nancy Lin, MD 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT04711824
What this trial is testing

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

Who this might be right for
Breast CancerBrain Metastases, Adult
Colette Shen 41
Large-scale testing (Phase 3)Looking for participantsNCT03750227
What this trial is testing

Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors

Who this might be right for
Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the Brain
Mayo Clinic 140
Testing effectiveness (Phase 2)Ended earlyNCT00496379
What this trial is testing

ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases

Who this might be right for
Breast CancerCNS Disease
Nancy Lin, MD 15
Testing effectiveness (Phase 2)Study completedNCT03520842
What this trial is testing

Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer

Who this might be right for
KRAS Gene MutationMetastatic Malignant Neoplasm in the BrainRecurrent Non-Small Cell Lung Carcinoma+1 more
Stanford University 22
Not applicableLooking for participantsNCT02504788
What this trial is testing

A Prospective Study of the Impact of Hippocampal Avoidance During Whole Brain Radiotherapy on Neurocognitive Function Decline

Who this might be right for
Brain MetastasisBrain Metastases
Chang Gung Memorial Hospital 100
Not applicableUnknownNCT02588924
What this trial is testing

Study on the Relationship Between Environmental and Occupational Exposure to Metals and Parkinson's Disease

Who this might be right for
Parkinson Disease, Secondary
University of Campania Luigi Vanvitelli 100
Not applicableStudy completedNCT07574112
What this trial is testing

Muscle Energy Technique With And Without Myofascial Release in Patients With Cervicogenic Headache

Who this might be right for
Cervicogenic Headache
University of Lahore 40
Not applicableLooking for participantsNCT06918964
What this trial is testing

TaVNS for Acute Intracerebral Hemorrhage

Who this might be right for
Intracerebral Hemorrhage
Beijing Tiantan Hospital 186
Testing effectiveness (Phase 2)Looking for participantsNCT07134153
What this trial is testing

Phase I/II Study of Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain Metastases

Who this might be right for
Breast Cancer
Fudan University 139
Testing effectiveness (Phase 2)Active Not RecruitingNCT05109364
What this trial is testing

Terazosin and Parkinson's Disease Extension Study

Who this might be right for
Symptomatic Parkinson DiseaseREM Sleep Behavior DisorderPre-motor Parkinson's Disease
Cedars-Sinai Medical Center 15
Not applicableStudy completedNCT06940167
What this trial is testing

Comparison of Kinesio Taping and Myofascial Release in Cervicogenic Headache

Who this might be right for
Cervicogenic Headache
Konya Meram State Hospital 81
Not applicableLooking for participantsNCT06802471
What this trial is testing

Efficacy and Central Mechanisms of Electroacupuncture for Medication Overuse Headache

Who this might be right for
Medication Overuse HeadacheElectroacupuncture
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 160
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Very early researchStudy completedNCT04895592
What this trial is testing

Radiosurgery Before Surgery for the Treatment of Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Solid Neoplasm
Emory University 26
Post-approval studies (Phase 4)Study completedNCT03971071
What this trial is testing

Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache

Who this might be right for
Migraine Headache
Amgen 620
Testing effectiveness (Phase 2)Study completedNCT00122044
What this trial is testing

Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects

Who this might be right for
Dystonia
University of Southern California 35
Not applicableStudy completedNCT02070172
What this trial is testing

Active and Passive Cervical Flexion-rotation Tests

Who this might be right for
Cervicogenic Headaches
Des Moines University 24
Early research (Phase 1)Active Not RecruitingNCT04192981
What this trial is testing

GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases

Who this might be right for
Brain MetastasesLeptomeningeal Metastasis
Memorial Sloan Kettering Cancer Center 21
Testing effectiveness (Phase 2)Looking for participantsNCT05673928
What this trial is testing

A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)

Who this might be right for
Metastatic Solid TumorBrain Metastases
M.D. Anderson Cancer Center 30
Next Page